Stock Information
Becton Dickinson and Co (BDX)
Ticker Symbol: BDX
Exchange: NYSE
Sector: Health Care
Market Cap: $58,113.72 mil
Piotroski score: 6
PE Ratio: 34.262
EPS (TTM): 5.8243
Revenue (TTM): $75.84 M
Dividend Yield: 2.0813715%
ROE: 6.63%
Latest News
-
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term
Mon, Jan 26, 2026 2:50 PM
-
Best Dividend Kings: January 2026
Sun, Jan 25, 2026 10:11 PM
-
Becton Dickinson & Co. stock outperforms competitors despite losses on the day
Fri, Jan 23, 2026 4:46 PM
-
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
Fri, Jan 23, 2026 11:50 AM
-
BD and Ypsomed’s Large‑Volume Biologic Autoinjector Collaboration Could Be A Game Changer For Becton Dickinson (BDX)
Thu, Jan 22, 2026 9:15 PM
-
BD and Ypsomed Expand Partnership to Target Growing Biologics Market
Thu, Jan 22, 2026 3:43 PM
-
BD and Ypsomed develop new version of Neopak XtraFlow syringe
Thu, Jan 22, 2026 11:13 AM
-
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors despite daily gains
Wed, Jan 21, 2026 4:47 PM
-
BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System
Wed, Jan 21, 2026 4:43 PM
-
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
Wed, Jan 21, 2026 11:50 AM
Key Financials
Financial data not available